Recursion Pharmaceuticals is a clinical-stage biotechnology company that leverages artificial intelligence, experimental biology, and automation to industrialize drug discovery. The platform combines high-throughput screening, computer vision, and machine learning to map and navigate biological relationships, accelerating the discovery and development of novel therapeutics. Recursion's approach involves generating large-scale datasets of biological images and using AI models to identify potential drug candidates, predict their efficacy, and optimize their development. The company focuses on rare genetic diseases, neurological disorders, inflammation, immunology, and infectious diseases.
We don't have vendor details for Recursion Pharmaceuticals AI Drug Discovery Platform yet. Know the provider's website?
Discover EU-based alternatives for this AI application.
